John E. Gill IV is a seasoned professional with 25 years of experience in the biotechnology industry, specializing in cell line development. Currently serving as the Senior Director of Cell Line Development at Gilead Sciences, they lead various aspects of platform evaluation and CMC program management. Previously, they held the position of Director and Head of Cell Line Generation at Shire, contributing to the development of multiple commercially approved products, and served as Principal Scientist at Samsung Biologics. John earned a B.S. in Microbiology from the University of New Hampshire and has a background in Korean language training from the U.S. Army Defense Language Institute.
This person is not in the org chart
This person is not in any teams
This person is not in any offices